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Summary 
Major histocompatibility complex (MHC) class I molecules act as peptide receptors to direct 
the recognition of foreign antigens by cytolytic T cells. The cell surface expression and trafficking 
of these peptide receptors is thought to be controlled by the conformation of the MHC molecule 
and possibly by the phosphorylation of the cytoplasmic portion of the heavy chain protein. It 
is of some interest that adenoviruses (Ads) have evolved proteins that interfere with the expression 
of MHC molecules.  One of these proteins, called E3/19k, binds to newly synthesized MHC 
molecules in the rough endoplasmic reticulum (RER) and inhibits their trafficking to the cell 
surface. Here we show that during the infection of a human cell line with Ad2, the phosphorylation 
of the endogenous MHC molecules is inhibited. We also observe that the phosphorylation of 
the endogenous HLA molecules is grossly impaired in a human cell line transfected  with the 
Ad2 EcoRI D fragment containing the E3/19k gene. We conclude that the E3/19k protein inhibits 
the phosphorylation of the MHC heavy chains and that this may be one of the important functions 
of this protein in infected cells. In addition, we show that a mutant of the E3/19k protein, which 
lacks an PER retention signal but which retains  its ability to bind to HLA molecules, does 
not inhibit the phosphorylation of HLA molecules and that phosphorylated molecules are not 
Endo H sensitive. This suggests that HLA molecules are phosphorylated after leaving the medial- 
Golgi compartment, thus providing the most compelling evidence yet that HLA molecules are 
phosphorylated at or near the cell surface. Finally, to our knowledge, this is the first study under 
which the phosphorylation of MHC molecules is shown to be altered and may have some relevance 
for other pathogenic conditions. 
T 
he mammalian class I antigens of the MHC are highly 
polymorphic  cell surface glycoproteins. One of their major 
functions is to bind and then present viral peptides to CTL 
after viral infection (1, 2). Though each individual MHC class 
I protein may bind only to a small set of peptides during 
viral infections (3-5), the extensive polymorphism between 
different MHC alleles and genes is believed to increase the 
capacity of this family of proteins to present a large variety 
of foreign viral antigens or peptides to virus-specific CTL. 
Thus, the extensive polymorphism may function on a popu- 
lation level to allow a species to withstand viral infections. 
With such a great deal of polymorphism between MHC 
class I molecules, it is perhaps worth considering the common 
features of these molecules.  They are composed of a heavy 
chain (mol wt 45,000) and a noncovalently associated light 
chain (mol wt 12,000) called fl2-microglobulin (6, 7). The 
heavy chain has three extracellular  domains, Oil, o~2, and oe3 
1 These  authors  contributed  equally  to  this  research  and  should  be 
considered as such. 
(8), each composed of ~90 amino acids, a transmembrane 
domain of "~30 amino acids, and a cytoplasmic region of 
"~30-40  residues  (8). The polymorphism resides primarily 
in the c~1 and a2 domains, whereas the oo domain and B2- 
microglobulin are relatively conserved (8). The protein do- 
main structure of the MHC class I antigens is consistent with 
the exon-intron organization of the corresponding genes (9). 
Thus, separate exons encode the signal sequence, the c~1, ol2, 
and c~3 domains, as well as  the transmembrane segment. 
Surprisingly, the cytoplasmic region is encoded by three mini- 
exons,  each of them containing the information for ~10 
amino acids (protein domains I1, I2, and Ia), and this region 
is a site of phosphorylation (10-14). The crystal structure of 
the human class I proteins, HLA-A2 (15, 16) and HLA-Aw68 
(17) confirms the domain structure and reveals that the oel 
and oe2 domains form a superdomain that is involved in pep- 
tide binding. This structure is stabilized by the a3 and B2- 
microglobulin domains, which lie proximal to the plasma 
membrane (15, 16). 
In addition to polymorphism arising from amino acid sub- 
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exist that increase their structural complexity. Alternative pro- 
cessing of MHC class I mRNA can result in modified tran- 
scripts thereby encoding several different proteins from a single 
gene (18, 19). For example,  exon VII, which encodes  part 
of the intracytoplasmic region of MHC class I heavy chains 
(I2), is a site of alternative splicing at the mRNA level (14, 
18, 19). Splicing of the VII exon can result in the omission 
of 13 amino acids in the MHC heavy chain protein (14). The 
I2 domain contains one site of serine phosphorylation at po- 
sition 335  and possibly an additional site  at position 332 
(12-14).  Thus, alternative splicing of the immature mlLNA 
may result in the removal of a peptide structure containing 
a phosphorylation site(s). It is tempting to speculate that this 
mechanism has some functional significance, and that coor- 
dinate expression of alternatively spliced forms results in func- 
tional modification of MHC molecules, but at present, the 
data are incomplete. However, the phosphorylation of MHC 
class I molecules has been implicated in determining endo- 
cytic uptake from the cell surface and may function in down- 
regulating surface expression of MHC class I molecules (10, 
11). The functional ramifications of this mechanism of down- 
regulation are not clear. 
The E3/19k protein of adenovirus 2 (Ad2)  2 is a rough en- 
doplasmic reticulum (REK) protein that spans the 1LEK mem- 
brane (20, 21). It is thought to be a prime mediator of viral 
persistence (22). It binds to MHC dass I proteins in the RER, 
inhibiting their passage to the cell surface (20, 21), and thereby 
reducing the recognition of infected cells by virus specific 
T cells (23-26).  This mechanism is thought to allow the virus 
to evade the host immune response  (22).  We originally de- 
signed experiments to test whether the E3/19k protein is phos- 
phorylated. This approach was chosen because  we wanted 
to test whether ADP-ribosylation is a common signal for PER 
retention shared between luminal R.EtL proteins such as BIP 
(27) and integral RElL membrane proteins like E3/19k. We 
found that the E3/19k is not phosphorylated. Conversely, 
MHC  molecules  that  are  normally  constitutively phos- 
phorylated are  nonphosphorylated in  cells  expressing the 
E3/19k protein. 
Materials and Methods 
Cell Culture, Cell Labelin,~ Imraunoprecipitation, and SDS-PAGE. 
Cell lines were derived and propagated as previously  described (28, 
29). Cells were maintained in DMEM or c~MEM containing 10% 
FCS. The 621.13 cell  line was the kind gift of  Dr. Svne  Kvist (Ludwig 
Institute,  Stockholm, Sweden). 
Metabolic labeling experiments were carried out essentially as 
described previously  (28, 29) with the following  modifications.  Cells 
to be metabolically  labeled were washed twice in methionine-free 
or phosphate-free media and incubated in the same media for 1 h 
at 37~  before being incubated at 37~  with [3SS]methionine 
(1,200 Ci/mmol, Amersham Corp., England) at a concentration 
2Abbreviations used in this paper: Ad, adenovirus; AFU, arbitrary fluo- 
rescence units; hpi, hours post-infection; KER, rough endoplasmic 
reticulum. 
of 100/~Ci/ml for 15 min or 250/~Ci/ml of 32p-orthophosphate 
(9,000 Ci/mmol, Amersham Corp.) for 2 h. The cells were washed 
twice in cold complete medium. At this point, the ceils were lysed 
on the plate (20 mM "Iris, pH 7.6, 120 mM NaC1, 4 mM MgCI~, 
1% NP-40, and 20 #g/ml PMSF). To clear the lysates from the 
cellular debris, the lysates  were spun at 38,000 g for 30 min. The 
supernatants were incubated with 3 #1 of normal rabbit serum on 
ice for 15 min. Protein A-Sepharose (100 #1 of a 1:1 bufferAepharose 
slurry) was then added, and the mixtures were incubated for an 
additional 60 rain before being spun at 14,000 g for 5 min. Im- 
munoprecipitations from the precleared lysates were carried out 
by incubating with 25 #1 of the rabbit antisera fluid or 100 #1 of 
mAb  supernatant  for  45  min,  followed by  45  #1  of protein 
A-Sepharose for 60 min. The beads were washed and the proteins 
were analyzed  by 10-15% SDS-PAGE and autoradiographed as de- 
scribed previously  (28, 29). When required, the beads were  incubated 
for 30 h with Endo H buffer (70 mM NaCitrate, pH 5.5) with 
or without 2.5 mU of Endo H before analysis by SDS-PAGE. 
Virus Propagation and Infection.  Ad2 was propagated and titrated 
on 293 cells as described previously (30). To assess the effect of 
Ad2 on the phosphorylation of MHC molecules, 293 cells were 
infected with Ad2 at an MOI of 50 or mock infected using PBS. 
After 40 min of adsorption at 37~  cells  were incubated  in DMEM 
containing calf serum and further incubated until metabolically  la- 
beled. HSV and CMV infection were carried out as described  above 
for Ad2 except that infections were carried out with a MOI of 
10. In the 0-2 h post-infection  (hpi) time points, infection  and phos- 
phate starvation were done simultaneously and labeling media was 
added immediately after adsorption. 
Antibodies.  Rabbit antisera reacting with the E3/19k protein 
from Ad2 was a kind gift from Dr. William Wold (St. Louis  Univer- 
sity, St. Louis, MO). W6/32 (anti-HLA-A, -B, -C) (31) was pre- 
pared from hybridoma supernatant. Goat anti-mouse IgG FITC 
was obtained from Southern Biotechnology. 
FACS |  To verify cell surface expression of the HLA antigen, 
FACS  |  analysis  was carried out (Becton  Dickinson & Corp., Moun- 
tain View, CA). Mock or virus-infected 293 cells or transfected 
293.12 and 621.13 ceils were harvested  from petri dishes  by washing 
the cells twice with PBS and then incubating with versene. A single 
cell suspension was prepared and the cells were then washed twice 
in PBS containing 0.5%  (wt/vol)  BSA, 20 mM NAN3, and 20 
mM Hepes. The cells were incubated with mAbs as previously de- 
scribed (28, 29), except that FITC-conjugated  goat anti-mouse IgG 
was used as the second-step reagent. After labeling, the cells were 
fixed in 1.5% (vol/vol) p-formaldehyde. The fluorescent profiles 
were obtained by analyzing 5,000 cells in a semi-logarithmic plot 
using a FACScan  |  program. Conversion of log scale to linear scale 
mean fluorescent values was carried out using the equation: linear 
mean fluorescence =  100o~  r~,n  auo~cen~/256  channels) 
Other Reagents.  Protein A-Sepharose was from Pharmacia Fine 
Chemicals (Uppsala, Sweden). 
Results 
The FACS  |  analysis shown in Fig. 1 reveals that human 
293 cells infected with Ad2 and then stained 20 h after infec- 
tion with a mAb (W6/32),  which binds to MHC class I 
heavy chains complexed to  B2-microglobulin (31), have  a 
much reduced level of HLA at their cell surface in compar- 
ison to mock-infected 293  cells. The mean average linear 
fluorescence is 33 arbitrary fluorescence units (AFU) for Ad2- 
infected (MOI 50) 293 cells. The mean average fluorescence 
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Figure 1.  Inhibition of MHC 
class I surface  expression  by AdZ 
293 cells were mock treated (b) or 
infected with Ad2 at a MOI of 50 
(c). At 20 hpi, cells were tryp- 
sinized  and  incubated  with 
W6/32 (anti HLA-A, -B, -C) and 
labeled with  goat  anti-mouse 
IgG-FITC. The samples were then 
analyzed by flow cytometry. The 
negative control (a; no first anti- 
body [NFA]) was mock-treated 
cells incubated  with the secondary 
antibody  only. The log values  con- 
verted to linear  values are: (a) NFA 
= 2 AFU; (b) mock = 93 AFU; 
and (c) Ad2-infected cells =  33 
AFU.  The inhibition of MHC 
surface  expression  was 66% in this 
particular experiment  and 61% + 
4 on average (six independent ex- 
periments). 
for mock-treated cell is 93 AFU. The no first antibody con- 
trol is the same for both cell treatments (2 AFU). Thus, the 
inhibition of MHC surface expression after Ad2 infection in 
the experiment shown was 66%. In six independent experi- 
ments,  the inhibition was on average 61%  +  4.  Similarly, 
293 cells stably transfected with an EcoRI D  fragment con- 
taining  the E3/19k  gene (20) also have reduced expression 
of MHC  molecules at the cell surface (Fig. 2). The average 
mean linear fluorescence of MHC class I molecules on 293 
cells is 271 AFU, as determined by the W6/32 antibody (sub- 
tracting the background fluorescence of 15 AFU).  The av- 
erage mean fluorescence of the HLA-A2 molecule expressed 
on 293 cells and analyzed with the PA2.1 antibody is 72 AFU. 
After subtraction of the background fluorescence of 9 AFU, 
the mean fluorescence of MHC class I molecules on 293.12 
cells is 41 AFU with the W6/32 antibody and 4 AFU with 
the PA2.1 antibody.  Thus,  the overall MHC class I inhibi- 
tion was 85% with the W6/32 antibody and 94% with the 
antibody PA2.1. In two separate experiments, the inhibition 
of the W6/32  binding  to 293.12  as compared to 293 cells 
was 84%  ___  2.  The inhibition of binding with  the PA2.1 
antibody was 94%  __.  1. These data show that Ad2 reduces 
the expression of HLA molecules at the cell surface of 293 
cells.  Furthermore,  the EcoRI D  fragment appears  to con- 
tain the gene or genes that are sufficient to mediate this pro- 
cess.  In addition,  Fig.  2  shows  that  the level of inhibition 
of HLA expression on 293.12 cells in comparison with 293 
cells as detected with an antibody that recognizes the HLA- 
A2 molecule (PA2.1) is similar to that seen with the W6/32 
antibody that recognizes a common determinant on all HLA 
molecules so far tested. Thus, the inhibition of HLA expres- 
sion in 293.12 cells is not likely to be a result of the masking 
of the W6/32 epitope by the binding of the E3/19k protein. 
Finally, we analyzed the cell surface expression of HLA mol- 
ecules in 293 ceils that have been transfected with a gene en- 
coding a mutant of the E3/19k protein (32), which lacks a 
RER retention signal (amino adds  134-142).  This protein, 
293  293.12  621.13 
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Figure 2.  Inhibition of MHC class I surface expression by transfected 
cells expressing  E3/19k. 293, 293.12 cells expressing the E3/19k protein, 
and 621.13 cells expressing the truncated E3/19k protein called 621 were 
trypsinized, washed, and analyzed  for the surface-expression  of MHC using 
W6/32 (anti-HLA-A, -B, -C; d-J) or PA2.1 (anti-HLA-A2; g-i) as the 
primary antibody and goat anti-mouse IgG-FITC as the secondary anti- 
body. Ceils were analyzed  by flow cytometry. Controls included NFA (in- 
cubated with the secondary  antibody only; a-c) and OKT9, which binds 
to the human transferrin receptor (/-/). Converted linear values are: (a) 
NFA  =  15 AFU; (d) W6/32  =  286 AFU; (g) PA2.1 =  87 AFU; and 
(/~ OKT9 =  60 AFU for 293 cells; (b) NFA  =  9 AFU; (e) W6/32  = 
50 AFU; (h) PA2.1 =  13 AFU; and (k) OKT9 =  55 AFU for 293.12 
cells; and (c) NFA =  16 AFU; (~ W6/32 =  228 AFU; (i) PA2.1 =  57 
AFU; and (/) OKT9 = 55 for 621.13 cells. In this experiment, inhibition 
of HLA-A, -B, -C surface expression in 293.12 cells was 85% as assessed 
with W6/32. HLA-A2 inhibition was 94% as analyzed with PA2.1. In 
two separate experiments, the inhibition was on average 84%  _+ 2 and 
94%  _+ 1, respectively.  Similarly, inhibition of MHC surface expression 
in 621.13 cells was 22% (26% _+ 4) with the W6/32 antibody and 43% 
(45%  _+ 4) with the PA2.1 antibody. 
designated 621,  retains its ability to bind HLA molecules, 
but the complex is transported through the cell (32). In 293 
cells stably transfected with the EcoRI D  fragment containing 
the 621 gene, the cell surface expression of HLA molecules 
is lower than in untransfected 293 cells (W6/32  =  22% in- 
hibition;  PA2.1  --  43%) with a mean in two experiments 
of 26%  +  4 with the W6/32 antibody and 45%  _+  4 with 
the PA2.1 antibody. Thus, the cell surface expression of HLA 
molecules is intermediate in 621 expressing 293 cells com- 
pared to untransfected and wild-type E3/19k-transfected 293 
cells. It is likely that HLA molecules form a complex with 
the 621 molecule at the cell surface (32). Extrapolating from 
this and previous results (20-22), it is reasonable to conclude 
that the E3/19k protein is mediating the cell surface inhibi- 
tion of HLA molecules in 293.12 and infected 293 cells and 
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tional  PER retention sequence in the E3/19k protein. 
To analyze the state of phosphorylation of HLA molecules 
in 293 cells infected with Ad2, cells were infected with Ad2 
and  then  metabolically  labeled  with  32p-orthophosphate 
from 20-22 hpi.  The cells were lysed in NP-40 containing 
lysis buffer, and the cellular debris was removed by ultracen- 
trifugation at 38,000 g for 30 rain. Antibodies against HLA 
molecules were used to specifically  immunoprecipitate these 
proteins from equal numbers of TCA-precipitable counts, as 
assessed by scintillation counting. The immunoprecipitates 
were analyzed on a 10-15%  gradient SDS-PAGE followed 
by autoradiography. In mock-infected 293 cells labeled with 
32p-orthophosphate (Fig.  3 A), MHC  proteins  are clearly 
phosphorylated.  In cells infected with Ad2, which encodes 
a functional E3/19k protein, the phosphorylated form of  MHC 
proteins is substantially inhibited.  This inhibition of phos- 
phorylation mirrors the maximum inhibition of HLA sur- 
face expression, which takes place 16-24 hpi (Fig. 1). Den- 
sitometry traces indicate that the phosphorylation of MHC 
class I molecules is reduced by ;>60% in Ad2-infected cells 
compared to mock-treated 293 cells. In five  independent ex- 
periments,  the decrease of phosphorylation was 66%  +_  4. 
In an attempt to generalize these findings to other viral 
systems, the phosphorylation of MHC molecules expressed 
in HSV- and CMV-infected cells was examined. Vero cells, 
which are permissive  for HSV-1 infections, were infected with 
HSV-1 and then metabolically labeled with 32p-orthophos- 
phate 22-24 hpi. The cell lysates were prepared as before and 
immunoprecipitations were carried out from equal numbers 
of TCA precipitable counts with the W6/32 antibody. Simi- 
larly, CMV was used to infect MRC5 cells, and the phos- 
phorylation of  MHC molecules was compared between virus- 
infected and noninfected cells. Fig. 3, B and C shows that 
there is little difference between the virus-infected and the 
mock-treated cells up to 22 hpi nor at times before this time 
(data not shown).  Thus, we conclude that two members of 
the herpes virus group, CMV and HSV-1, do not inhibit the 
phosphorylation levels of MHC molecules up to 22 hpi. 
Figure 4.  Reduction of the level of MHC phosphorylation in trans- 
fected cells expressing  E3/19k.  293,  293.12 cells expressing the E3/19k 
protein, and 621.13 cells expressing the 621 protein were pulse labeled for 
30 rain with 3SS-methionine or 2 h with szP-orthophosphate  and lysed. 
MHC (c~MHC) or E3/19k (cxE3/19k) molecules were immunoprecipi- 
rated from equal trichloroacetic counts and analyzed by SDS-PAGE and 
autoradiography.  A longer exposure of the 3sS autoradiogram reveals the 
presence  of both MHC and B2M in the immunoprecipitates using the 
c~E3/19k antibody (data not shown). Separate experiments were analyzed 
by densitometry and indicated a reduction of phosphorylation of the MHC 
molecules  of 81%  +  4 in 293.12 cells (six experiments) and a level of 
phosphorylation of 134%  •  37 in 621.13 cells (four experiments) com- 
parable  to 293 cells). 
We next wanted to determine if the Ad2 E3/19k protein 
was able to inhibit the phosphorylation of the MHC mole- 
cules or if there are other Ad-encoded proteins involved in 
this process. Human 293 cells, which had been transfected 
with the EcoRI D fragment of Ad2 containing the E3/19k 
Figure 3.  Effect of different viruses on the phosphory- 
lation of MHC class I. 293,  Vero, or M1LC5 cells were 
infected with Ad2 (MOI  =  50), HSV-1 (MOI  =  10), or 
CMV (MOI  =  10), respectively, or mock treated. The 
cells were labeled for 2 h with 32p-orthophosphate at 20 h 
(Ad2) or 22 h (HSV-1 and CMV) post-infection. The cells 
were lysed and MHC molecules were immunoprecipitated 
using the W6/32 antibody and analyzed by SDS-PAGE 
and autoradiograpby. Equal TCA-precipitable counts were 
used for the immunoprecipitations. The position of the 
32p-labeled heavy  chain  of  MHC  (MHC)  as  well  as 
the virtual migration positions of E3/19k (E3/19k) in the 
adenovirus immunoprecipitates  and the light chain (flzM) 
are shown on the right side. The molecular masses of the 
protein standards  (in kD) are indicated on the left side. 
Densitometry analysis  indicated that the reduction of phos- 
phorylation of MHC by Ad2 is 66%  +_ 4 on average (five 
independent experiments). 
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containing the 621 gene (32), or untransfected 293 cells, were 
metabolically labeled with either 3SS-methionine or with 32p. 
orthophosphate and immunoprecipitations were carried out 
as described above.  In 3SS-methionine-labeled  293.12  cells, 
the antibody against MHC proteins clearly immunoprecipi- 
tates the MHC molecule  with the E3/19k bound to it, whereas 
in the untransfected 293 cells HLA, but not the E3/19k pro- 
tein, was detected (Fig.  4). In addition, the 621 protein can 
be detected by coimmunoprecipitation with HLA molecules 
in 621-transfected cells. The 621 runs at a slightly lower mo- 
lecular weight than the E3/19k protein in coimmunoprecipi- 
ration with HLA molecules (Fig. 4). Unfortunately, the rabbit 
antisera we are using was raised against a synthetic peptide 
(33) that corresponds to the PER retention signal absent in 
the 621 protein (32).  Thus, we can not analyze this protein 
directly. 
In the 293 cells metabolically labeled with 32p-orthophos- 
phate, HLA class I molecules are phosphorylated. However, 
in the E3/19k transfectant the phosphorylation of the MHC 
is dramatically inhibited. The weak signal that does appear 
represents 24% of the HLA phosphorylation level in 293 cells 
(mean of 19%  +  4 in five independent experiments). The 
immunoprecipitations were carried out from equal numbers 
of TCA-precipitable counts. Normalization of the 32p label- 
ing with the 35S-methionine  labeling reveals an even greater 
level of inhibition of HLA phosphorylation. The small amount 
of phosphorylated HLA in 293.12 cells may be molecules that 
avoid binding to the E3/19k protein or they may represent 
a form of the HLA molecules that are phosphorylated at an 
alternative site other then serine 335, which is not affected 
by the E3/19k protein. The identity of this molecular form 
of phosphorylated HLA molecules is under investigation. We 
conclude that the EcoRI D  fragment of Ad2 contains the 
information necessary to transfer the inhibition of phosphory- 
lation of HLA molecules. In addition, we conclude that the 
E3/19k  protein is not itself phosphorylated (Fig.  4). 
We next wanted to determine whether the retention of 
HLA molecules in the RER was responsible for the inhibi- 
tion of HLA phosphorylation or whether it was a result of 
an additional activity associated with the E3/19k  protein. 
We therefore analyzed the phosphorylation of HLA mole- 
cules in the presence of the 621  protein.  We find that the 
phosphorylation of HLA molecules is not effected in these 
cells (Fig. 4). The apparent increase in the level of phosphory- 
lation of the MHC molecules shown in this particular ex- 
periment (239% compared to 293 cells) is not reproducible 
(134%  _+  37 in four experiments). We infer from this data 
that the inhibition of phosphorylation is a consequence of 
inhibiting HLA transport through the cell. Alternatively, the 
COOH-terminal RER retention signal absent in the 621 pro- 
tein  contains  an  activity that  directly mediates the hypo- 
phosphorylation of HLA molecules. 
Finally,  the glycosylation of the phosphorylated forms of 
HLA molecules in 293 and 293.12 cells was analyzed. HLA 
molecules from 32p-labeled 293 and 293.12 cells were immu- 
noprecipitated in duplicate. One of each of the samples was 
digested overnight in buffer containing Endo H. The dupli- 
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Figure 5.  Glycosylation  of the phosphorylated  forms of MHC mole- 
cules in 293 and 293.12 cells. 293 and 293.12 cells expressing  the E3/19k 
protein were pulsed  labded for 2 h with 32p-orthophosphate,  and MHC 
class I molecules  were  immunoprecipitated  with the W6/32 antibody.  The 
immunoprecipitates  were  mock  treated  (-) or digested  with Endo H (+) 
overnight  and analyzed  by SDS-PAGE  and autoradiography.  Figure  symbols 
are as previously  noted. M, protein molecular  mass standards. The OVA 
in the molecular  mass standards  is sensitive  to Endo H digestion  and was 
used as a control for the effidency  of digestion. In this experiment,  the 
reduction  of  phosphorylation,  as determined  by densitometry  tracing  was 
91%. 
cates of these samples were incubated in buffer alone. Endo 
H  resistance is a marker of glycoproteins that have left the 
cis/medial Golgi compartment. At the end of the incubation 
SDS-PAGE loading buffer was added, and the samples were 
separated by SDS-PAGE.  The gel was dried and autoradiog- 
raphy was performed. Fig.  5  shows that  the vast majority 
of phosphorylated HLA molecules in 293 or 293.12 cells are 
not Endo H  sensitive.  This experiment suggests that HLA 
molecules  become  phosphorylated  after  they  leave  the 
cis/medial  Golgi  compartment.  It  also  suggests  that  the 
majority of the phosphorylated form of the HLA molecules 
seen in the 293.12 cells are molecules that have escaped E3/19k- 
mediated retention in  the PER. 
Discussion 
Ads have developed several mechanisms for evading the host 
immune system (17,  20,  21,  34).  In fact, the E3 region of 
Ad, which is dispensable for viral replication in tissue cul- 
ture (34),  may act as a specific expression cassette for down- 
regulating the host immune response. The E3/19k protein 
is likely to be the most abundant protein encoded by the E3 
region (34).  It binds to MHC class I molecules in the RER, 
thereby inhibiting their transport to the cell surface (20, 21). 
It appears  that the E3/19k protein is arranged in functional protein domains including an intraluminal domain that in- 
teracts with a region of the c~1 and or2 domains of MHC 
class I molecules (28). This region of class I MHC molecules 
also controls their rate of transport to the cell surface. A second 
domain acts jointly as a stop transfer sequence and a trans- 
membrane region. Finally, the cytoplasmic tail of the mole- 
cule appears  to contain the information for confining the 
E3/19k molecule, and the MHC protein to which it is bound, 
to the RER  (35). 
Protein phosphorylation is thought to regulate several cel- 
lular processes  including signal transduction,  mitosis,  cell 
proliferation, cell motility, cell shape,  and gene regulation 
(36).  Its role in the trafficking of proteins through the exo- 
cytic pathway is only now being assessed. The study of MHC 
class I molecules provides an opportunity for determining 
the rules for phosphorylational control of protein transport. 
A great deal is known about how MHC class I assembly and 
conformation control their passage through the cell. For ex- 
ample, it is known that the variation between the MHC heavy 
chain alleles controls their rate of transport through the cell 
(28), binding to peptides (3), and the binding of the E3/19k 
protein (28).  We also know that peptides bind during the 
assembly of class I heavy chains with ~2-microglobulin (37). 
Furthermore, site-specific phosphorylation including and in 
addition to the major site of phosphorylation at serine 335 
may modulate distinct routing of MHC class I molecules 
through the cell (10, 11). Finally, alternative splicing of exon 
VII, which contains the major sites of phosphorylation in 
MHC class I molecules, may yet prove to have a profound 
effect on the antigen-presenting function of class I molecules 
(10, 11, 14). Unfortunately, we are still lacking a direct demon- 
stration that HLA class I molecules become phosphorylated 
exclusively at the plasma membrane. The only real support 
for this is that PMA, a potent activator of plasma membrane- 
associated protein kinase C, causes hyperphosphorylation of 
HLA molecules (10) and that deletion of exon VII containing 
two phosphorylation sites alters  the rate of endocytosis of 
HLA molecules (10,  11). In the present study, we sought 
to approach this issue. 
During infection with Ad2, we find that the cell surface 
expression of MHC molecules decreases (Fig.  1). This effect 
is maximized 16-20 hpi. The level of phosphorylation of the 
MHC molecules was measured at the peak of the inhibition 
of MHC surface expression. To show that the inhibition of 
phosphorylation is not merely a result of the lowered expres- 
sion of MHC molecules after infection with Ad2, we exam- 
ined a cell line that constitutively expresses the E3/19k pro- 
tein. We found that we could detect the binding of the E3/19k 
protein to MHC molecules. Furthermore, the phosphoryla- 
tion of MHC molecules is dramatically reduced in the cells 
that express the E3/19k protein.  We conclude from these 
studies that the E3/19k protein can inhibit the phosphoryla- 
tion of MHC class I proteins. Recently, it was shown that 
the EcoKI D fragment of Ad2 encodes another protein, 6.7k 
(38). The role of this protein in the formation of the E3/19k- 
MHC class I complex is unknown but is under investigation. 
The mechanism by which the E3/19k protein reduces the 
level of MHC class I heavy chain phosphorylation is still un- 
clear. We decided to examine if the E3/19k protein inhibits 
the phosphorylation of MHC molecules by inhibiting their 
transport out of the REK,  if it acts directly on the MHC 
proteins to inhibit phosphorylation, or if it actively dephos- 
phorylates MHC molecules. For example, does phosphory- 
lation of MHC molecules control their egress or transport 
to the cell surface. We therefore examined HLA phosphory- 
lation in 293 cells expressing a form of the E3/19k protein 
called 621, which lacks a peptide from the COOH terminus, 
which confers REK retention to the HLA-E3/19k complex 
(35). The 621 protein retains its ability to bind to HLA class 
I proteins. We found that phosphorylation is not inhibited 
in cells expressing the 621 protein. Therefore, either the PER 
retention signal actively participates in dephosphorylating or 
inhibiting the phosphorylation of HLA molecules, or reten- 
tion in the RER does not allow HLA molecules to gain access 
to enzymes that phosphorylate them. We favor the latter sce- 
nario, as it would suggest that HLA molecules must leave 
the KER/cis-Golgi compartments in order to become fully 
phosphorylated. In further support of this hypothesis is the 
demonstration that the vast majority of phosphorylated HLA 
molecules expressed in 293 and 293.12 cells are not Endo H 
sensitive (Fig. 5). This suggests that the HLA molecules must 
leave the cis/medial Golgi in order to become phosphorylated 
and that most of the residually phosphorylated HLA mole- 
cules expressed in 293.12 cells are molecules that have escaped 
E3/19k mediated retention in the REK. In this regard, this 
is the best data yet presented that HLA molecules are indeed 
phosphorylated in a cellular compartment beyond the medial 
Golgi compartment, and it supports the notion that HLA 
molecules may become phosphorylated at the cell surface. 
In the future, our ability to modify MHC molecules and 
to express them in cell lines (28) and transgenic animals (29) 
should allow us to determine the exact role of MHC class 
I protein phosphorylation. In addition, the E3/19k protein 
may be useful as a tool to alter the phosphorylation of MHC 
class I molecules. Regardless of the outcome of these experi- 
ments, the results reported here add another level of com- 
plexity to the molecular pathogenesis of Ads. 
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